Pacira BioSciences, Inc. — Director's Dealing 2020

Mar 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira BioSciences, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2020-03-11

Reporting Person: WINSTON ROY (Chief Clinical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-11	Common Stock	P	2500	$36.50	Acquired	25237	Direct

Footnotes

F1: Includes 598 shares of common stock acquired under the issuer's employee stock purchase plan in June 2019.